Literature DB >> 35619667

Change in binding affinity with ACE2 receptor in beta, delta and omicron SARS CoV2 variants.

Rujittika Mungmunpuntipantip1, Viroj Wiwanitkit2.   

Abstract

BACKGROUND: COVID-19 is still an important public health problem. After a pandemic, there is already new emerging mutant type of COVID-19. Starting from mutant with few mutations, the new mutant types with several mutations occur. Omicron variant is the new variant of concern that starts outbreak from Africa and might be the new problem worldwide.
METHOD: Pathogenesis may change as a result of molecular changes. An important possible effect of mutation is a change in binding affinity with receptor. Here, the authors performed a study to assess the effect of mutations of ACE2 receptor binding affinity in important COVID-19 variants, beta, delta and omicron variants.
RESULTS: According to the analysis, change of binding affinity to receptor in each studied mutated variant comparing to classical wild type SARS CoV2 is observed.
CONCLUSION: This exploratory research on changes in ACE2 receptor binding affinity revealed that changes do occur and may contribute to the pathophysiology. The omicron variation has a greater degree of alteration than the well-known significant variants, beta and delta. Rapid spread due to simpler transmission is envisaged as a result of affinity modification. Nevertheless, the authors only examined the affinity with bioinformatics analysis. It is different from experimental analysis, therefore, it may not real and further studies are required for confirmation. IJPPP
Copyright © 2022.

Entities:  

Keywords:  ACE2; COVID-19; Omicron; binding; receptor; variant

Year:  2022        PMID: 35619667      PMCID: PMC9123474     

Source DB:  PubMed          Journal:  Int J Physiol Pathophysiol Pharmacol        ISSN: 1944-8171


  4 in total

Review 1.  The Global Epidemic of the SARS-CoV-2 Delta Variant, Key Spike Mutations and Immune Escape.

Authors:  Dandan Tian; Yanhong Sun; Jianming Zhou; Qing Ye
Journal:  Front Immunol       Date:  2021-11-30       Impact factor: 7.561

Review 2.  Analysis of the Delta Variant B.1.617.2 COVID-19.

Authors:  Shayan Shiehzadegan; Nazanin Alaghemand; Michael Fox; Vishwanath Venketaraman
Journal:  Clin Pract       Date:  2021-10-21
  4 in total
  1 in total

1.  Computation of the Binding Energies between Human ACE2 and Spike RBDs of the Original Strain, Delta and Omicron Variants of the SARS-CoV-2: A DFT Simulation Approach.

Authors:  Serhan Yamacli; Mutlu Avci
Journal:  Adv Theory Simul       Date:  2022-09-13
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.